Please use this identifier to cite or link to this item:
Title: Ozone therapy as adjuvant for cancer treatment: Is further research warranted?
Authors: Clavo, Bernardino 
Santana Rodríguez, Norberto
Llontop, Pedro
Gutiérrez, Dominga
Suárez, Gerardo
López, Laura
Rovira, Gloria
Martínez-Sánchez, Gregorio
González, Esteban
Jorge, Ignacio J.
Perera, Carmen
Blanco, Jesús
Rodríguez Esparragón, Francisco Javier 
UNESCO Clasification: 32 Ciencias médicas
Keywords: Animal Experimental Examinations
Spinal-Cord Stimulation
Tumor Oxygenation
Chromosome Breakage
Irradiated Tumors
Oxidative Stress
Advanced Head
Neck Tumors
Issue Date: 2018
Publisher: 1741-427X
Journal: Evidence-Based Complementary and Alternative Medicine 
Abstract: Introduction. This article provides an overview of the potential use of ozone as an adjuvant during cancer treatment. Methods. We summarize the findings of the most relevant publications focused on this goal, and we include our related clinical experience. Results. Over several decades, prestigious journals have published in vitro studies on the capacity of ozone to induce direct damage on tumor cells and, as well, to enhance the effects of radiotherapy and chemotherapy. Indirect effects have been demonstrated in animal models: immune modulation by ozone alone and sensitizing effect of radiotherapy by concurrent ozone administration. The effects of ozone in modifying hemoglobin dissociation curve, 2,3-diphosphoglycerate levels, locoregional blood flow, and tumor hypoxia provide additional support for potential beneficial effects during cancer treatment. Unfortunately, only a few clinical studies are available. Finally, we describe some works and our experience supporting the potential role of local ozone therapy in treating delayed healing after tumor resection, to avoid delays in commencing radiotherapy and chemotherapy. Conclusions. In vitro and animal studies, as well as isolated clinical reports, suggest the potential role of ozone as an adjuvant during radiotherapy and/or chemotherapy. However, further research, such as randomized clinical trials, is required to demonstrate its potential usefulness as an adjuvant therapeutic tool.
ISSN: 1741-427X
DOI: 10.1155/2018/7931849
Source: Evidence-Based Complementary And Alternative Medicine[ISSN 1741-427X]
Appears in Collections:Reseña
Adobe PDF (2,9 MB)
Show full item record


checked on Feb 28, 2021


checked on Feb 28, 2021

Page view(s)

checked on Mar 1, 2021


checked on Mar 1, 2021

Google ScholarTM




Export metadata

Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.